Low back pain (LBP) is the leading cause of disability worldwide, with an estimated 80% of the American population suffering from a painful back condition at some point during their lives.
| INTRODUCTION
The Global Burden of Disease study of 2015 identified lower back pain (LBP) as the leading cause of disability worldwide. 1 Indeed, it is estimated that 80% of Americans will suffer from a painful back condition at some point during their lives. 1 The most common cause is degeneration of the intervertebral disc (IVD), with a prevalence of 39%-42% in LBP patients. 2 IVD degeneration (IVDD) can occur as a natural part of the aging process, or as a consequence to cellmediated responses to structural failure. 3, 4 Medical management of LBP is primarily focused on the treatment of symptomatic pain, which may alleviate clinical signs but does not restore IVD function. Surgical management strategies can address structural problems with the disc, but have failure rates as high as 40% due to incomplete decompression, spinal instability, alteration of the vertebral column's biomechanics, epidural scar tissue formation or iatrogenic nerve injury. 5, 6 Thus, there is a critical need to investigate the pathophysiology of painful IVDD and resultant LBP in order to develop safe, successful and less invasive clinical treatments.
Experimental animal models are vital for understanding the mechanisms of painful IVDD and for the early stages of developing therapeutic strategies; however, these models have some limitations that may impact their predictive value when translating an intervention from the laboratory to the clinical setting. Of recent interest from the translation perspective is the canine "chondrodystrophic" (CD) model of IVDD, which is a spontaneous clinical model of IVDD occurring in pet dogs. IVDD affects upwards of 20% of certain breeds of dogs such as the miniature dachshund. 7 In North America alone, between 20,000 and 30,000 cases of spontaneously occurring IVDD in pet dogs are managed by veterinary spinal specialists each year. 8 As a result, the canine IVDD population is highly amenable to large scale veterinary clinical studies which can be conducted with adherence to CONSORT guidelines, National Institutes of Health (NIH) standards for scientific transparency and rigor, and can closely recapitulate a human clinical trial condition. 9, 10 Of significant note, unlike most other animal models, dogs with spontaneous IVDD commonly present to the veterinary clinic with IVDD-associated pain. 11 Degeneration of the canine IVD also occurs spontaneously, making pathologic processes associated with IVDD in this species highly relevant to the human condition. Additionally, the size of a typical dog with spontaneous IVDD addresses many "scaling up" issues encountered in the direct translation of therapies from rodents to humans. Lastly, the use of pet dogs with spontaneous IVDD can contribute to reduction, refinement, and replacement of 
| THE HEALTHY IVD
The general structure of the IVD is well-conserved across vertebrate species, and serves to counteract the compressive forces of the body that are placed upon the vertebral column while also acting as joints to promote motion and flexibility. 12 Under healthy conditions, the IVD is composed of the annulus fibrosus (AF), which consists of concentric lamellae of collagen type I, elastin, and fibroblast-like cells, and encloses the proteoglycan-rich NP. 13 The NP and AF are formed from the embryonic notochord and surrounding mesenchyme, respectively, during development of the IVD. 13, 14 The dense collagen lamellar structure of the AF provides tensile strength and stability to the vertebral column by contributing to overall rigidity. 15 The NP is a hydrated mixture of cells, aggrecan and collagen type II 16 . Aggrecan helps to imbibe water, creating a gelatinous NP core that distributes load across the disc and absorbs compressive forces. 17 The transitional zone (TZ) or inner AF region separates the AF from the NP in the mature IVD. 18 The IVD is avascular, relying on the permeability of the adjacent cartilaginous endplates (CEPs) to receive nutrition. [19] [20] [21] [22] The CEP is a layer of hyaline cartilage covering the vertebral bodies that isolates the disc from the rest of the vertebral column. 22 In addition to being avascular, the healthy IVD is aneural, and can be viewed as a site of immune-privilege. 24, 25 as seen in the gelatinous and less translucent NP in Figure 1B . CD dogs typically lose their notochordal cells as they reach skeletal maturity, usually within the first year of life, while humans lose theirs by approximately 10 years of age. 26 Since notochordal cells protect the NP from degradation and apoptosis, their loss is associated with an imbalance in matrix turnover and catabolism of the IVD. 27 In contrast, rodents, rabbits and most NCD dogs retain a population of notochordal cells within the IVD and thus maintain a healthy balance of matrix turnover, resulting in preservation of the structural integrity and function of the IVD. 27 While there is an association between a loss of notochordal cells and disc degeneration, this has not been unequivocally established and there are likely additional factors (ie, genetics, lifestyle, comorbidities) that are involved.
| Mild changes
Proteoglycan content of the NP is maximized during young adulthood and begins a slow and steady decline shortly thereafter due to increased fragmentation and simultaneous increase in collagen content. 20, 27 The demarcation between the NP and AF becomes less apparent as the collagen fibrils of the AF encroach upon the NP ( Figure 1C ).
During this transition, the overall cellularity of the IVD declines and the disc becomes more fibrous with increased collagen deposition. 28 
| Moderate and late-stage changes
The avascular nature of the IVD causes it to lack the innate ability to appropriately heal and repair. 11, 21 Changes in the NP as a result of maturation affect the biomechanics of the IVD and ultimately lead to "wear and tear," whereby continued strenuous activities enhance matrix degradation over synthesis. 29 This inability to counteract compressive forces places additional strain on the AF, leads to AF degeneration including cleft and crack formation, and reduces its contributions to the overall strength of the vertebral column ( Figure 1D ). 17 Aging also leads to calcification of the CEP, which reduces porosity within the CEP structure itself and decreases disc access to nearby blood vessels and nutrition, enhancing a decline in cellularity. Lactic acid accumulation alters the cellular microenvironment within the disc, slowing matrix production but not matrix enzyme activity. 30 Upregulation of inflammatory and catabolic responses in degeneration can lead to increased expression of vascular endothelial growth factor (VEGF) and nerve growth factor (NGF), resulting in the invasion of nerves and blood vessels ( Figure 1E ). 31 These changes in disc environment lead to changes in structure function as well as contribute to pain mechanisms. and measure pain resulting from degenerative processes. While rodents are useful for pain assessment, they do not meet the previously stated criteria, and pain cannot be adequately measured in the rabbit, cow or pig models. Table 1 summarizes the criteria necessary for modeling human IVDD with a comparison of animal models discussed in this review.
As seen, the CD canine model most closely matches the human condition for reasons to be discussed in the following section. Character- has been classically believed to be two clinically distinct forms, described by Hansen as type I and type II IVDD. 48 Hansen type I IVDD is described as dehydration, degeneration and dystrophic calcification of the NP of the IVD, and is most commonly observed in CD dog breeds such as the dachshund, beagle, shih tzu, lhasa apso, and
Pekingese. Within these breeds, the supply of notochordal cells within the NP matrix is replaced with CLCs, often as early as A small number of studies have begun characterizing disc degeneration in the canine model, including comparisons between the CD and NCD breeds as shown in Table 2 . While these studies characterize the degenerate process in NCD and CD species they do not high- Spinal surgery is also often performed for canine "patients" with neurologic deficits or refractory pain. cytes. 81, 82 This results in an increased number of CEP irregularities compared to those observed dogs. 11 The canine vertebral growth plates close at skeletal maturity (~8 months) whereas in people, secondary ossification centers (ring apophysis) develop during teenage years then close at skeletal maturity. 83 The canine vertebral column contains growth plates throughout, which are responsible for the majority of vertebral growth. This species difference is relevant for histologic and imaging-based grading of IVDD and CEP changes, but is unlikely to affect translational relevance. 18 Differences in spinal biomechanics between canine and human, namely the quadrupedal nature of the dog placing the spine at a horizontal nature vs the vertical human spine due to bipedalism, must also be considered. Recent investigations however, have demonstrated that the axial loading effects are similar across the vertebral column in both species, suggesting that biomechanical differences may be less relevant than might be expected. 11, 29, 84 Indeed, ligaments and muscle play a key role in the stabilization of the spine both in bipeds and quadrupeds. Table 3 have demonstrated the positive regenerative potential of CLCs via increases in cell viability, matrix production and disc height integrity; however, CLC treatment is limited in both human and canine patients based on the stage of IVDD and is most beneficial at earlier stages. 86, 90, 91 Recently, the safety and feasibility of autologous bone marrow- such as PCLA-PEG-PCLA (poly(ε-caprolactone-co-lactide)-b-poly(ethylene glycol)-bpoly(ε-caprolactone-co-lactide)), agarose, and polyester amides. [104] [105] [106] Additionally, hydrogels have also been used to encapsulate drugs for delivery into the IVD. [105] [106] [107] These various therapies, as summarized, demonstrate the potential of the CD dog model as a clinically relevant model to evaluate regenerative IVDD therapies which can later translate to human conditions. However, unexplored is the potential of using organ culture as a tool to investigate and screen biological therapies for IVDD. 
| OPPORTUNITIES FOR FUTURE EXPLORATION

| ARE CHONDRODYSTROPHIC DOGS A GOOD TRANSLATIONAL MODEL FOR HUMAN IVDD?
This review summarizes and evaluates the criteria necessary for qualifying animal models of IVDD for use in translational application to the human condition, as is visible in Table 1 . As summarized in Future work should focus on defining the inflammatory and symptomatic profiles associated with painful IVDD to allow for the better understanding of how these relate to those observed in human IVDD.
